Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence

Roswell Park Cancer Institute · with National Cancer Institute (NCI) · NCT06323044

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Any age listed · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
150
US sites recruiting
1
Study start
February 11, 2025
Record last updated
August 12, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

This clinical trial identifies and addresses barriers to pediatric medication adherence among families of children with acute lymphoblastic leukemia. Pediatric nonadherence (noncompliance) to medication is a significant public health problem, and rigorous research repeatedly documents that nonadherence increases risk for hospitalization, healthcare cost, disease progression, and death. Pediatric acute lymphoblastic leukemia (ALL) patients who miss 5% of 6-mercaptopurine (6-MP) doses within the 2-year 6-MP regimen have a 2.7-fold risk of cancer that comes back after a period of improvement (relapse). To address these families' needs, researchers have developed MedSupport, a theory-based multilevel intervention with targets at the organizational, healthcare team, and caregiver levels that is designed to address root barriers to medication adherence. This study is being done to better understand families' experiences giving their child oral chemotherapy at home and to help families cope with the day-to-day challenges of giving their child medication.

Being studied: Best Practice; Biospecimen Collection; Electronic Health Record Review; Interview; Medical Device Usage and Evaluation; Medical Device Usage and Evaluation; Survey Administration

Conditions: Acute Lymphoblastic Leukemia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Parent of a child diagnosed with acute lymphoblastic leukemia (ALL)
  • Child patient age 365 days to \< 19 years at time of study entry.
  • Parent's child patient's therapy must include 6-mercaptopurine (6-MP) administered orally or by nasogastric (NG) tube.
  • Verbal fluency in English, or Spanish
  • Parent has a smartphone or computer access with an Internet connection.
  • Participant must understand the investigational nature of this study and sign an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedure.

Exclusion Criteria

  • Parent is unwilling or unable to follow protocol requirements.

Recruiting US locations

  • Roswell Park Cancer Institute

    Buffalo, NY 14263

    Site contact: Kara M. Kelly · 716-845-2333 · Kara.Kelly@RoswellPark.org

All healthy volunteers studies in New York →
MedSupport Intervention to Identify and Address Barriers to… (NCT06323044) | Bored Studies